Results 81 to 90 of about 16,441 (147)

Factor Xa inhibitors vs. warfarin in patients with Hughes syndrome: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Mohtashim A, Azhar A, Mazhar S, Devi D, Danial M, Patel D, Khan O, Andani A, Khan MM, Samad S, Qureshi A, Ali H, Ejaz U, Jawad S.   +13 more
europepmc   +1 more source

Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair. [PDF]

Cochrane Database Syst Rev
Salazar CA, Basilio Flores JE, Malaga G, Malasquez GN, Bernardo R.   +4 more
europepmc   +1 more source

The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis. [PDF]

Circulation
Siegal DM, Forbes N, Eikelboom J, Beyer-Westendorf J, Cohen AT, Xu L, Connolly SJ, Crowther M.   +7 more
europepmc   +1 more source

Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter Most. [PDF]

Stroke Vasc Interv Neurol
Concha M, Xu L, Horn M, Ohara T, Nakamya J, Beyer-Westendorf J, Shoamanesh A, Cohen A, Ladenvall P, Connolly SJ, Demchuk AM.   +10 more
europepmc   +1 more source

Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]

J Clin Med
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Aranda U, Hernández I, García M, Lledó L, Arenillas JF.   +9 more
europepmc   +1 more source

Clinical Characteristics and Incidence of Hemorrhagic Complications in Patients Taking Factor Xa Inhibitors in Spain: A Long-Term Observational Study. [PDF]

J Clin Med
Escobar C, Palacios B, Villarreal M, Gutiérrez M, Capel M, Hernández I, García M, Lledó L, Arenillas JF.   +8 more
europepmc   +1 more source

Factor Xa inhibitors versus low-molecular-weight heparin for preventing coagulopathy following COVID-19: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Amin L, Qayyum K, Uzair M, Khan F, Sethi P, Hanif L, Azhar A, Mazhar S, Ejaz U, Jawad S.   +9 more
europepmc   +1 more source

Factor Xa inhibitors versus warfarin in patients with non-valvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Med Surg (Lond)
Zahoor MM, Mazhar S, Azhar A, Mand Khan F, Anees U, Vohra RR, Ejaz U, Jawad S.   +7 more
europepmc   +1 more source

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers. [PDF]

Clin Pharmacokinet
Rohr BS, Krohmer E, Foerster KI, Burhenne J, Schulz M, Blank A, Mikus G, Haefeli WE.   +7 more
europepmc   +1 more source

Efficacy and safety of oral factor Xa inhibitors versus vitamin-K antagonists in the early phase after acute ischemic stroke or TIA in the real-world setting: The PRODAST study. [PDF]

Eur Stroke J
Diener HC, Grosse GM, Hüsing A, Stang A, Kuklik N, Brinkmann M, Maurer GD, Soda H, Pohlmann C, Hilker-Roggendorf R, Popovic N, Kraft P, Mackert BM, Eschenfelder CC, Weimar C.   +14 more
europepmc   +1 more source